Projectes

IrsiCaixa compta amb un centenar de projectes de recerca nacionals i internacionals actius cada any, finançats tant per entitats públiques com privades.

Paraules clau

Grup de recerca

Investigador/a

Des del

Fins el

Characterisation of single molecule dynamics within HIV-1 reservoirs as a target for interference with virus persistence and immune evasion

Estatus del projecte

Vigent

Inici/Fi

2019

/

2020

Investigador/a principal

Javier Martínez-Picado

Jakub Chojnacki

Entitat finançadora

European Comission (H2020)
SIGTECH - New technologies mimicking virus-cell interaction to fight infectious diseases

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Nuria Izquierdo Useros

Entitat finançadora

Grifols
VIROCURE - Cutting edge strategies on HIV cure

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Grifols
Exploratory, open-label, randomized clinical trial to assess the efficacy of first-line dual vs. triple antiretroviral therapy in HIV-1 reservoir and in peripheral compartments in HIV-infected patients

Estatus del projecte

Vigent

Inici/Fi

2019

/

2021

Investigador/a principal

Javier Martínez-Picado

Personal investigador extern

José Moltó

Entitats participants

AIDS Research Institute IrsiCaixa

Línia estratègica

Malalties infeccioses globals

Entitat finançadora

ViiV Healthcare
Glycoengineering nanovehicles to purge viral reservoirs

Estatus del projecte

Vigent

Inici/Fi

2018

/

2021

Investigador/a principal

Nuria Izquierdo Useros

Entitats participants

ICN2 and Biofisika-CISC

Entitat finançadora

Spanish Ministry of Economy and Competitiveness, ref. SAF2017-91767-EXP.
Halt the entry of enveloped viruses into immune cells: novel monoclonal antibodies and blockage of intracellular cascade

Estatus del projecte

Vigent

Inici/Fi

2020

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute

Línia estratègica

Immunopatologia de les malalties

Entitat finançadora

Spanish Ministry of Science and Innovation
3D human organoids for biomarker identification and treatment assessment in COVID-19 (3D4COVID)

Estatus del projecte

Vigent

Inici/Fi

2020

/

2021

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute, Pompeu Fabra University (UPF)

Línia estratègica

Càncer

Malalties infeccioses emergents

Entitat finançadora

Merck SARS-CoV-2 competitive international call
Allogeneic Stem Cell Transplantation in HIV-1 Infected Individuals (IciStem)

Estatus del projecte

Vigent

Inici/Fi

2015

/

2017

Investigador/a principal

Javier Martínez-Picado

Personal investigador extern

Annemarie Wensing (University Medical Center Utrecht)

Entitats participants

Institut de Recerca de la Sida IrsiCaixa; Universitair Medisch Centrum Utrecht (Països Baixos); Hospital Gregorio Marañón (Madrid); Churchill Hospital, Oxford University Hospitals (Regne Unit); Institut Pasteur, París (França); Universitätsklinikum Hamburg-Eppendorf (Alemanya); Cellex (Dresden, Alemanya).

Línia estratègica

Immunopatologia de les malalties

Malalties infeccioses globals

Teràpies i vacunes

Web

IciStem

Entitat finançadora

Foundation for AIDS research amfAR; (ARCHE program) 109293-59-RGRL
CRISPR Screen to Identify Drug- Repurposing Host Targets for SARS-CoV-2 Infection (CRISPR-CoV2)

Estatus del projecte

Vigent

Inici/Fi

2020

/

2021

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute, Pompeu Fabra University

Línia estratègica

Càncer

Malalties infeccioses emergents

Entitat finançadora

CRUE Spanish Universities
HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI/r Based Regimen. A Phase IV Open Randomized Trial

Estatus del projecte

Vigent

Inici/Fi

2015

/

2017

Investigador/a principal

Javier Martínez-Picado

Personal investigador extern

Manel Crespo (Hospital Universitari de la Vall d’Hebron)

Entitats participants

Institut de Recerca de la Sida IrsiCaixa; Hospital Universitari de la Vall d’Hebron; Universitair Ziekenhuis Gent (Gant, Bèlgica)

Línia estratègica

Immunopatologia de les malalties

Microbioma

Malalties infeccioses globals

Entitat finançadora

ViiV Healthcare